TONIX PHARMACEUTICALS HLDG C

Historical 13F Holders

Symbol
TNXP
CUSIP
890260839
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 890260839 since 12/18/2024, newest first.

Filer % of Class Filed
Sirenia Capital Management LP 13G/A Amendment 1
4.9% 8/14/2026
Event 6/30/2026
AQR Capital Management, LLC 13G
5.5% 8/13/2026
Event 6/30/2026
Millennium Management LLC 13G
5.6% 6/15/2026
Event 6/9/2026
Point72 Asset Management, L.P. 13G/A Amendment 1
6.9% 5/15/2026
Event 3/31/2026
Sirenia Capital Management LP 13G
8.8% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 2 0% 3/27/2026
Event 3/13/2026
Vanguard Group Inc 13G/A Amendment 1 5.0% 1/30/2026
Event 12/31/2025
BlackRock, Inc. 13G/A Amendment 2 6.7% 1/21/2026
Event 12/31/2025
Point72 Asset Management, L.P. 13G
9.2% 12/31/2025
Event 12/29/2025
Vanguard Group Inc 13G 6.4% 10/31/2025
Event 9/30/2025
BlackRock, Inc. 13G/A Amendment 1 7.8% 10/17/2025
Event 9/30/2025
BlackRock, Inc. 13G 5.7% 7/17/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 986 $9.60 k
2026 Q2 109 9.36 M $120 M
2026 Q1 88 4.87 M $67.0 M
2025 Q4 76 3.74 M $58.5 M
2025 Q3 65 2.36 M $57.1 M
2025 Q2 49 1.39 M $50.1 M
2025 Q1 27 477 k $8.53 M
2024 Q4 2 5.38 k $1.77 k